Latest APTO reports update at 2024-05-14: 2024-Q12023-Q42023-Q1
Aptose Biosciences logo
Aptose Biosciences APTO
$ 0.89 -4.3%

Aptose Biosciences Balance Sheet 2011-2024 | APTO

Annual Balance Sheet Aptose Biosciences

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-8.24 M -35.7 M -38.5 M -116 M -78.3 M -15.3 M -10.6 M -7.93 M -8.29 M -17.4 M -634 K 563 K -933 K

Long Term Debt

621 K 1 M 115 K - - - - - - 487 K - - -

Long Term Debt Current

394 K 301 K 459 K 539 K 521 K - - - - - - - -

Total Non Current Liabilities

- - - 535 K 1.01 M - - - - 487 K - - -

Total Current Liabilities

15.3 M 12.3 M 8.17 M 6.81 M 5.54 M 2.79 M 1.76 M - - - - - -

Total Liabilities

15.9 M 13.3 M 8.29 M 7.35 M 6.55 M 2.79 M 1.76 M 1.32 M 1.7 M 2.27 M 1.76 M 2.62 M 1.19 M

Deferred Revenue

- - - - - - - - - - - - -

Retained Earnings

-516 M -464 M -423 M -357 M -302 M -276 M -247 M -187 M -168 M -194 M -194 M -189 M -194 M

Total Assets

13 M 51 M 82.5 M 126 M 100 M 16.9 M 12 M 8.64 M 15.3 M 28.5 M 1 M 648 K 2.05 M

Cash and Cash Equivalents

9.25 M 37 M 39.1 M 117 M 79.8 M 15.3 M 10.6 M - - - - - -

Book Value

-2.9 M 37.7 M 74.2 M 119 M 93.9 M 14.1 M 10.2 M 7.32 M 13.6 M 26.2 M -758 K -1.97 M 865 K

Total Shareholders Equity

-2.9 M 37.7 M 74.2 M 119 M 93.9 M 14.1 M 10.2 M 7.33 M - - - - -

All numbers in USD currency

Quarterly Balance Sheet Aptose Biosciences

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

520 K 621 K 720 K 817 K 918 K 1 M 1 K - 10 K 115 K 218 K 321 K 420 K 535 K 535 K 535 K 535 K 1.01 M 1.01 M 1.01 M 1.01 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

12.7 M 15.9 M 13.1 M 12.8 M 13.3 M 13.3 M 10.2 M - 7.32 M 8.29 M 8.52 M 8.03 M 5.79 M 7.35 M 7.35 M 7.35 M 7.35 M 6.55 M 6.55 M 6.55 M 6.55 M 2.79 M 2.79 M 2.79 M 2.79 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-525 M -516 M -504 M -492 M -478 M -464 M -454 M - -434 M -423 M -398 M -387 M -373 M -357 M -357 M -357 M -357 M -302 M -302 M -302 M -302 M -276 M -276 M -276 M -276 M -247 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

12.8 M 13 M 20.9 M 26.6 M 39.3 M 51 M 57 M - 72.6 M 82.5 M 97.2 M 106 M 115 M 126 M 126 M 126 M 126 M 100 M 100 M 100 M 100 M 16.9 M 16.9 M 16.9 M 16.9 M 12 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

7.35 M 9.25 M 15.7 M 8.4 M 22.8 M 37 M 28 M - 37 M 39.1 M 75.1 M 83.3 M 87.1 M 117 M 117 M 117 M 117 M 79.8 M 79.8 M 79.8 M 79.8 M 15.3 M 15.3 M 15.3 M 15.3 M 10.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

137 K -2.9 M 7.78 M 13.8 M 26 M 37.7 M 46.8 M - 65.3 M 74.2 M 88.7 M 98.2 M 109 M 119 M 119 M 119 M 119 M 93.9 M 93.9 M 93.9 M 93.9 M 14.1 M 14.1 M 14.1 M 14.1 M 12 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

137 K -2.9 M 7.78 M 13.8 M 26 M 37.7 M 46.8 M 55.5 M 65.3 M 74.2 M 88.7 M 98.2 M 109 M 119 M 119 M 119 M 119 M 93.9 M 93.9 M 93.9 M 93.9 M 14.1 M 14.1 M 14.1 M 14.1 M 10.2 M 9.82 M 10.3 M 7.77 M 7.33 M - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency